Cardiology
Cardiology CME
Earn Cardiology CME that fits how you practice. ReachMD offers practical, on-demand Cardiology CME/CE designed for cardiologists, fellows, APPs, and the full cardiovascular care team. Explore short, case-based activities and expert discussions across heart failure, interventional cardiology, electrophysiology, imaging, prevention, and more. Use this page to find your next activity fast. Browse learning tracks, jump into trending topics, or choose a series from our partner academies and clinical-practice resources. New activities are added regularly, so you can stay current with emerging evidence and evolving standards of care while earning credit on your schedule.
Start an activity below to earn credit or browse by topic to find the Cardiology CME most relevant to your practice.
121-135 of 212
ns-MRAs: The Cardiovascular-Kidney-Metabolic Connection
MinuteCE®ns-MRAs: The Cardiovascular-Kidney-Metabolic Connection
Csaba P. Kovesdy, MD
Finnian R. McCausland, MD
Love Story: Lipid Education for Women’s Heart Health
CME/CE Broadcast ReplayLove Story: Lipid Education for Women’s Heart Health
Pam R. Taub, MD, FACC, FASPC
Ira J. Goldberg, MD
Kausik Ray, MBChB, MD, MPhil
Christie Ballantyne, MD
Optimizing HF Outcomes Across the Spectrum: Emerging Evidence
MinuteCE®Optimizing HF Outcomes Across the Spectrum: Emerging Evidence
Akshay S. Desai, MD
John McMurray, MD
Akshay S. Desai, MD
John McMurray, MD
Gianluigi Savarese, MD, PhD, FESC, FHFA
James Burton, DM, FRCP
Aaron Wong, MD
- advertisement
New Horizons: Unraveling Novel Therapies for Enhanced Cardiovascular Outcomes in Patients With Heart Failure
CME/CENew Horizons: Unraveling Novel Therapies for Enhanced Cardiovascular Outcomes in Patients With Heart Failure
Carolyn Lam, MD, PhD
Scott Solomon, MD
Mikhail Kosiborod, MD
Partnering for Progress: A Case Study in Patient-Centered Hyperkalemia Management
CME/CEPartnering for Progress: A Case Study in Patient-Centered Hyperkalemia Management
David Wheeler, MB, CHB, MD, FRCP
Prof. John Kastelein, Chief Scientific Officer, NewAmsterdam Pharma
Stephen Nicholls, FRACP, FACC, FESC, FAHA
Erin Michos
A novel CETP inhibitor to target CV risk reduction: Where could it fit in future lipid management?
MinuteCE®A novel CETP inhibitor to target CV risk reduction: Where could it fit in future lipid management?
Erin Michos
CETP inhibition: Lessons from two decades of clinical trials
MinuteCE®CETP inhibition: Lessons from two decades of clinical trials
Stephen Nicholls, FRACP, FACC, FESC, FAHA
What do we know now that could have changed the history of CETP inhibition?: genetics and biology
MinuteCE®What do we know now that could have changed the history of CETP inhibition?: genetics and biology
Prof. John Kastelein, Chief Scientific Officer, NewAmsterdam Pharma
- advertisement
Updates From the 7th World Symposium Task Force
CME/CEUpdates From the 7th World Symposium Task Force
Eric D. Austin, MD, MSCI
Hilary M. DuBrock, MD
H. James Ford, MD
Gustavo A. Heresi, MD, MS
Gergely Meszaros, JD, MSc
Oksana A. Shlobin, MD
Ioana Preston, MD
Lucilla Piccari, MD, PhD
Understanding the etiology of HCM and pathways for intervention
MinuteCE®Understanding the etiology of HCM and pathways for intervention
Roberto Barriales-Villa, MD, PhD
Perry Elliott, MD
Roberto Barriales-Villa, MD, PhD
Iacopo Olivotto, MD
